Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum

Toxicology

Volumn 226, Issue 2-3, 2006, Pages 238-245

  Wu, Ping Ho ^a   Shen, Yuh Chiang ^b   Wang, Yea Hwey ^a   Chi, Chin Wen ^a,c   Yen, Jiin Cherng ^a,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Baicalein; Lipid peroxidation; Methamphetamine; Myeloperoxidase; Neuroprotection

Indexed keywords

BAICALEIN; DOPAMINE TRANSPORTER; MALONALDEHYDE; METHAMPHETAMINE; MYELOPEROXIDASE; NEURONAL NITRIC OXIDE SYNTHASE; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CORPUS STRIATUM; ENZYME ACTIVITY; LEUKOCYTE; LIPID PEROXIDATION; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FLAVANONES; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; NEOSTRIATUM; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE I; PEROXIDASE; REACTIVE OXYGEN SPECIES;

EID: 33747825104     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.06.015     Document Type: Article

References (28)

1. Açikgöz O., Gönenç S., Kayatekin B.M., Uysal N., Pekçetin C., Şemin I., and Güre A. Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum. Brain Res. 813 (1998) 200-202
2. Ajjimaporn A., Swinscoe J., Shavali S., Govitrapong P., and Ebadi M. Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells. Brain Res. Bull. 67 (2005) 466-475
3. Asanuma M., Tsuji T., Miyazaki I., Miyoshi K., and Ogawa N. Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug. Neurosci. Lett. 352 (2003) 13-16
4. Cadet J.L., Jayanthi S., and Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17 (2003) 1775-1788
5. Chang W.S., Lee Y.J., Lu F.J., and Chiang H.C. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res. 13 (1993) 2165-2170
6. Deng X., and Cadet J.L. Methamphetamine administration causes overexpression of nNOS in the mouse striatum. Brain Res. 851 (1999) 254-257
7. Fleckenstein A.E., Metzger R.R., Beyeler M.L., Gibb J.W., and Hanson G.R. Oxygen radicals diminish dopamine transporter function in rat striatum. Eur. J. Pharmacol. 334 (1997) 111-114
8. Flora G., Lee Y.W., Nath A., Maragos W., Hennig B., and Toborek M. Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. Neuromol. Med. 2 (2002) 71-85
9. Gao Z., Huang K., Yang X., and Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim. Biophys. Acta 1472 (1999) 643-650
10. Gluck M.R., Moy L.Y., Jayatilleke E., Hogan K.A., Manzino L., and Sonsalla P.K. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J. Neurochem. 79 (2001) 152-160
11. Hanasaki Y., Ogawa S., and Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic. Biol. Med. 16 (1994) 845-850
12. Hara H., Sukamoto T., Ohtaka H., Abe K., Tatumi Y., Saito Y., Suzuki A., and Tsukamoto G. Effects of baicalein and alpha-tocopherol on lipid peroxidation, free radical scavenging activity and 12-O-tetradecanoylphorbol acetate-induced ear edema. Eur. J. Pharmacol. 221 (1992) 193-198
13. Hashimoto K., Tsukada H., Nishiyama S., Fukumoto D., Kakiuchi T., Shimizu E., and Iyo M. Protective effects of N-acetyl-l-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine. Neuropsychopharmacology 29 (2004) 2018-2023
14. Hwang Y.S., Shin C.Y., Huh Y., and Ryu J.H. Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats. Life Sci. 71 (2002) 2105-2117
15. Ishige K., Schubert D., and Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med. 30 (2001) 433-446
16. Itzhak Y., and Ali S.F. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67 (1996) 1770-1773
17. Itzhak Y., Gandia C., Huang P.L., and Ali S.F. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J. Pharmacol. Exp. Ther. 284 (1998) 1040-1047
18. Lebeau A., Esclaire F., Rostene W., and Pelaprat D. Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. Neuroreport 12 (2001) 2199-2202
19. Lerouet D., Beray-Berthat V., Palmier B., Plotkine M., and Margaill I. Changes in oxidative stress, iNOS activity and neutrophil infiltration in severe transient focal cerebral ischemia in rats. Brain Res. 958 (2002) 166-175
20. Liou K.-T., Shen Y.-C., Chen C.-F., Tsao C.-M., and Tsai S.-K. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res. 992 (2003) 159-166
21. Middleton Jr. E. Some biological properties of plant flavonoids. Ann. Allergy 61 (1988) 53-57
22. Miura Y.H., Tomita I., Watanabe T., Hirayama T., and Fukui S. Active oxygens generation by flavonoids. Biol. Pharm. Bull. 21 (1998) 93-96
23. Shen Y.-C., Chiou W.-F., Chou Y.-C., and Chen C.F. Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur. J. Pharmacol. 465 (2003) 171-181
24. Theodore S., Cass W.A., and Maragos W.F. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum. Exp. Neurol. 199 (2006) 490-498
25. Trulson M.E., Cannon M.S., Faegg T.S., and Raese J.D. Effects of chronic methamphetamine on the nigral-striatal dopamine system in rat brain: tyrosine hydroxylase immunochemistry and quantitative light microscopic studies. Brain Res. Bull. 15 (1985) 569-577
26. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., and Kish S.J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2 (1996) 699-703
27. Yen J.C., Chan J.Y.H., and Chan S.H.H. Differential roles of NMDA and non-NMDA receptors in synaptic responses of neurons in nucleus tractus solitarii of the rat. J. Neurophysiol. 81 (1999) 3034-3043
28. Yu J., Cadet J.L., and Angulo J.A. Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. J. Neurochem. 83 (2002) 613-622